Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01570153 · ClinicalTrials.gov registry record
Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 100
- Enrollment target
NCT01570153: Completed study, sponsored by Massachusetts General Hospital.
NCT01570153 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01570153 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the ability of a non-invasive monitor that measures how much fluid is in the body as well as various blood tests for their ability to predict worsening kidney function in patients with heart failure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01570153
The ClinicalTrials.gov registry entry for NCT01570153 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01570153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01570153 about?
NCT01570153 is a clinical study titled "Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial". The purpose of this study is to evaluate the ability of a non-invasive monitor that measures how much fluid is in the body as well as various blood tests for their ability to predict worsening kidney function in patients with heart failure.
What is the current status of trial NCT01570153?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2012-03. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT01570153?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.